The incidence of fake, expired, adulterated, mislabelled or otherwise unauthorized medicinal products reaching the market place is on the increase. The pharmaceutical industry itself is also at major risk. Today, it loses sales revenue to counterfeiters and product diverters. If this activity gets out of control and major tragedies happen, which it can, the resulting product recalls, brand damage and when stock price falls this will cause major financial impact at a time when drug company profits are already under extreme pressure.
